Bluestar Genomics closes $70M Series C funding, expands scientific advisory board

Must Read

Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the company had raised $70 million in new equity funding. Led with the …

Latest News

Bongal’s discovery may reshape Islam history in Indonesia: BRIN

Jakarta (ANTARA) - Indonesia's National Research and Innovation Agency (BRIN) stated a series of archaeological discoveries at Bongal Site...

More Articles Like This